Teva UK Limited Enters Wounds Sector With PolyHeal(TM) Launch
Monday, November 15, 2021 7:09 AM

Related Stories

CASTLEFORD, England, Nov. 15, 2010 (PR Newswire Europe) --

/PRNewswire/ -- Teva UK Limited, a leading supplier of medicines to the NHS, has today entered the Wound Care sector with the launch of PolyHeal (TM) at the Wounds UK conference. PolyHeal is a product for hard-to-heal wounds and has been clinically shown to result in a significant reduction in wound size after just one month's treatment - even in wounds with exposed bones and tendons.

The product consists of negatively charged polystyrene microspheres, suspended in a nutrient medium, which interact with cellular components within the wound bed to activate the inflammatory and proliferation phases of wound healing(1,2). It has clinically proven results in treating hard-to-heal wounds across a variety of wound types(3):

- Granulation coverage in 63% of wounds after four weeks - 40% wound size reduction after four weeks - 36% of wounds closed within 12 weeks

The results of two open-label studies of chronic wounds of multiple aetiologies - including venous, diabetic and ischaemic ulcers - showed that 87% of patients treated with PolyHeal achieved significant wound improvement after four weeks of treatment3. Furthermore, all exposed bones and tendons were covered after four weeks3.

Speaking at the launch, Robyn Hughes, Primary & Secondary Care Director at Teva, said: "We're delighted to bring this exciting new product to the UK market and believe it will make a real difference to patients suffering from hard-to-heal wounds." Marketing Manager, Dr Andrew Ellis, added: "There remains an unmet need in the treatment of chronic wounds - we are confident that PolyHeal will become a cornerstone of therapy in this challenging market segment."

The product will be available from wholesalers in January 2011.

To find out more about Teva UK Limited, visit

Notes to Editors: References: 1) Dulbecco's Modified Eagle's Medium (DMEM) 2) PolyHeal(TM) Instructions For Use 3) Zeilig G. et al. Study to evaluate PolyHeal-1 in treatment of recalcitrant wounds. DOF November 2010

About Teva UK Limited

Teva UK Limited is one of the UK's top ten pharmaceutical manufacturers, with a presence in the generics, branded respiratory and hospitals markets. It has the widest range of any UK generic pharmaceutical company and markets solid and liquid dose, injectable and respiratory medicines to healthcare professionals. The company is part of Teva Pharmaceutical Industries Ltd.

About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in 59 countries.

Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone(R), is the number one prescribed treatment for multiple sclerosis. Teva employs over 40,000 people around the world and reached $13.9 billion in net sales in 2009.


For media enquiries, contact the Teva UK Limited Communications team on +44(0)1977-628500, or email

CONTACT: For media enquiries, contact the Teva UK Limited Communications
team on +44(0)1977-628500, or email

(Source: PR Newswire )
(Source: Quotemedia)


Symbol :


Market news:

  • US lawmakers may vote on Armenian genocide measure Dec 18, 2021 04:03 AM

    • WASHINGTON - The House may vote next week on a measure that could damage U.S. relations with critical ally Turkey: a resolution declaring the World War I-era killings of Armenians a genocide.
    • House Democratic leaders had long set aside consideration of the draft resolution, and the measure was expected to expire as a new Republican-led House takes office next month.
    • House aides, speaking on condition of anonymity because they were not authorized to comment, said Friday that Democratic leaders have been discussing a possible vote with lawmakers.
      • Paris Vogue editor to leave after 10-year tenure Dec 18, 2021 03:56 AM

        • PARIS - Paris Vogue says its editor-in-chief, Carine Roitfeld, has decided to leave after a 10-year tenure in which the French fashion monthly became "a worldwide reference and indispensable magazine."
        • The magazine says on its Web site that Roitfeld's years as the top editor were marked by "constant growth" both in terms of circulation and advertising.
        • Xavier Romatet, the head of Conde Nast France, the French arm of the U.S. publishing house, said he "of course" regrets Roitfeld's decision to leave "even if I understand it."
          • James has triple-double, dominates again at MSG Dec 18, 2021 03:56 AM

            • NEW YORK - LeBron James always said he loved playing here.
            • James delivered another vintage performance at Madison Square Garden, scoring 32 points and finishing with his 30th career triple-double to help the Miami Heat beat the New York Knicks 113-91 for their 11th straight victory.
            • 6 jersey he hoped would belong to James - New York surged back to tie it at 57 at halftime.
              • $7.2B is recovered for Madoff's victims Dec 18, 2021 03:48 AM

                • NEW YORK - Many of Bernard Madoff's victims who thought they lost everything could get at least half their money back after the widow of a Florida philanthropist agreed Friday to return a staggering $7.2 billion that her husband reaped from the giant Ponzi scheme.
                • Picower was the single biggest beneficiary of Madoff's fraud.
                • He commended Picower's widow, Barbara, "for agreeing to turn over this truly staggering sum, which really was always other people's money."
                  • Congress rushes to finish bills before holidays Dec 18, 2021 03:48 AM

                    • WASHINGTON - Rushing to finish by Christmas, congressional Democrats worked Friday to secure Senate ratification of a new arms control treaty and to end the military's ban on openly gay service members as they neared the end of two tumultuous years of single-party government.
                    • Legislation to keep the federal government running until mid- to late February was also on the agenda, a matter for negotiations with emboldened Republicans who will take control of the House and add to their numbers in the Senate come January.
                    • He was looking for several more on his wish list - the arms control treaty and repeal of the military gay ban - to close out a politically tough year.

                      More news


    Recent Estimates

AnalystFirm NameSymbolEPS Estimate
jomariXXXXX CVG$0.31
mrbilltraderXXXXX POT$1.59
sam farahanXXXXX TECD$0.95
adfgafg ERTS$0.48